Tech Company Financing Transactions
Satori Pharmaceuticals Funding Round
Satori Pharmaceuticals, based in Cambridge, secured $15 million from Polaris Partners and PureTech Ventures.
Transaction Overview
Company Name
Announced On
5/1/2007
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
PureTech Ventures (Daphne Zohar)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
281 Albany Street
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Ives
VP - R & D
Brian Bronk
VP - R & D
Barbara Tate
Browse more venture capital transactions:
Prev: 5/1/2007: ProVina venture capital transaction
Next: 5/2/2007: SquareOne venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs